[1. https://ghr.nlm.nih.gov/primer/precisionmedicine/precisionvspersonalized]Search in Google Scholar
[2. https://obamawhitehouse.archives.gov/blog/2015/01/30/precision-medicine-initiative-data-driven-treatments-unique-your-own-body]Search in Google Scholar
[3. Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G, Oosterhuis W, et al. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53(6):833-5. DOI: 10.1515/cclm-2015-006710.1515/cclm-2015-006725719329]Open DOISearch in Google Scholar
[4. Elizabeta Topic, Nora Nikolac, Mauro Panteghini, Elvar Theodorsson, Gian Luca Salvagno, Marijana Miler, et al How to assess the quality of your analytical method?, Clin Chem Lab Med 2015; 53(11): 1707-18. DOI: 10.1515/cclm-2015-086910.1515/cclm-2015-086926408611]Open DOISearch in Google Scholar
[5. Federica Braga, Mauro Panteghini, Verification of in vitro medical diagnostics (IVD) metrological traceability: Responsibilities and strategies. Clinica Chimica Acta. May 2014;432:55-61. DOI: 10.1016/j.cca.2013.11.02210.1016/j.cca.2013.11.02224291059]Open DOISearch in Google Scholar
[6. Siest G, Henny J, Grasbeck R, Wilding P, Petitclerc C, Queralto JM, et al. The theory of reference values: an unfinished symphony. Clin Chem Lab Med 2013;51:4764. DOI: 10.1515/cclm-2012-068210.1515/cclm-2012-068223183761]Open DOISearch in Google Scholar
[7. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline third edition CLSI document C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.]Search in Google Scholar
[8. Graham R.D. Jones, Rainer Haeckel, Tze Ping Loh, Ken Sikaris, Thomas Streichert, Alex Katayev, et al, on behalf of the IFCC Committee on Reference Intervals and Decision Limits, Indirect methods for reference interval determination review and recommendations, Clin Chem Lab Med. 2019;57(1):20-29. DOI: 10.1515/cclm-2018-007310.1515/cclm-2018-007329672266]Search in Google Scholar
[9. Hoffmann RG. Statistics in the practice of medicine. JAMA.1963;185:864-873. DOI: 10.1001/jama.1963.0306011006802010.1001/jama.1963.0306011006802014043090]Open DOISearch in Google Scholar
[10. Katayev A, Balciza C, Seccombe WD, Establishing Referance Intervals for Clinical Laboratory Test Results -is there a better way? Am J Clin Pathol, 2010, 130, 180-186. DOI: 10.1309/AJCPN5BMTSF1CDYP10.1309/AJCPN5BMTSF1CDYP20093226]Search in Google Scholar
[11. Totan M, Gligor FG, Bojita M, Grigore C, Grigore C. Determining hemoglobin reference values in children and teenagers from Sibiu area. Rev Romana Med Lab. 2013;21(1):39-45. DOI: 10.2478/rrlm-2013-001610.2478/rrlm-2013-0016]Open DOISearch in Google Scholar
[12. Antonescu E, Szakács J, Totan M. Determination of reference intervals for total calcium and magnesium specific for children and adolescents in Sibiu area. Rev Romana Med Lab. 2016;24(3):347-50. DOI: 10.1515/rrlm-2016-003010.1515/rrlm-2016-0030]Open DOISearch in Google Scholar
[13. Catalin Codreanu, Horatiu Popoviciu, Elena Rezus, Corina Delia Mogosan, Ioannis Gardikiotis, Claudiu Costinel Popescu, Reference interval and upper limit of normal for serum uric acid an evidence-based approach on Romanian population using an a posteriori method, Rev Romana Med Lab. 2019;27(2):147-158. DOI: 10.2478/rrlm-2019-001910.2478/rrlm-2019-0019]Open DOISearch in Google Scholar
[14. Agnihotri S, Mittal RD, Kapoor R, Mandhani A. Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy. Indian J Med Res. 2014;139:851-6.]Search in Google Scholar
[15. Xavier Filella,Esther Fernández-Galan,Rosa Fernández Bonifacio, Laura Foj Emerging biomarkers in the diagnosis of prostate cancer. Pharmgenomics Pers Med. 2018 May;1611:83-94. DOI: 10.2147/PGPM.S13602610.2147/PGPM.S136026596164329844697]Open DOISearch in Google Scholar
[16. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. ESC Scientific Document Group, Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019 Jan 14;40(3):237-269. DOI: 10.1093/eurheartj/ehy46210.1093/eurheartj/ehy46230165617]Open DOISearch in Google Scholar
[17. Hadadi L, Sus I, Lakatos EK, Serban RC, Scridon A, Demjen Z, et al. Platelet indices and platelet-to-lymphocyte ratio predict coronary chronic total occlusion in patients with acute ST-elevation myocardial infarction. Rev Romana Med Lab. 2015;23(4):407-14. DOI: 10.1515/rrlm-2015-004110.1515/rrlm-2015-0041]Open DOISearch in Google Scholar
[18. Martha O, Porav-Hodade D, Bălan D, Tătaru OS, Sin A, Chibelean CB, et al. Easily Available Blood Test Neutrophil-To-Lymphocyte Ratio Predicts Progression in High-Risk Non-Muscle Invasive Bladder Cancer. Rev Romana Med Lab. 2017;25(2):181-9. DOI: 10.1515/rrlm-2017-001610.1515/rrlm-2017-0016]Open DOISearch in Google Scholar
[19. Balaban DV, Popp A, Beata A, Vasilescu F, Jinga M. Diagnostic accuracy of red blood cell distribution width-to-lymphocyte ratio for celiac disease. Rev Romana Med Lab. 2018;26(1):45-50. DOI: 10.2478/rrlm2018-004010.2478/rrlm2018-0040]Open DOISearch in Google Scholar
[20. Siegbahn A, Hijazi Z, Lindback J, Oldgren J, Pol T, Alexander JH, et al Screening for novel prognostic biomarkers associated with major bleeding by proximity extension assay in petients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial, abstract ESC Congress, Aug 2018.10.1093/eurheartj/ehy563.P4797]Search in Google Scholar
[21. Hutanu A, Iancu M, Balasa R, Maier S, Dobreanu M Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array, Acta Pharmacologica Sinica 2018: 39(7): 122836. DOI: 10.1038/aps.2018.2610.1038/aps.2018.26628933129926842]Search in Google Scholar
[22. Daraban AM, Trifa AP, Popp RA, Botezatu D, Șerban M, Uscatescu V, et al. Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms. Rev Romana Med Lab. 2016;24(3):291-305. DOI: 10.1515/rrlm2016-003210.1515/rrlm2016-0032]Open DOISearch in Google Scholar
[23. Mărginean A, Bănescu C, Moldovan V, Scridon A, Mărginean M, Bălaşa R, et al. The impact of CYP2C19 loss-of-function polymorphisms, clinical, and demographic variables on platelet response to clopidogrel evaluated using impedance aggregometry. Clin Appl Thromb. 2017; 23:255-65. DOI: 10.1177/107602961662921110.1177/107602961662921126873108]Open DOISearch in Google Scholar
[24. Sabin O, Bocșan IC, Trifa A, Major ZZ, Heghes SC, Brusturean Bota E, et al. Correlation between ABCB1 gene polymorphisms, antiepileptic drug concentrations and treatment response. Rev Romana Med Lab. 2018;26(4):479-87. DOI: 10.2478/rrlm-2018-001210.2478/rrlm-2018-0012]Open DOISearch in Google Scholar
[25. Selleck MJ, Senthil M, Wall NR. Making Meaningful Clinical Use of Biomarkers. Biomark Insights. 2017. 12:1177271917715236. DOI: 10.1177/117727191771523610.1177/1177271917715236547942828659713]Search in Google Scholar
[26. https://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/ucm330711.htm, accessed on april 2019]Search in Google Scholar
[27. Goossens N, Nakagawa S, Sun X, Hoshida Y Cancer biomarker discovery and validation, Transl Cancer Res. 2015 Jun; 4(3): 256–269. DOI: 10.3978/j.issn.2218676X.2015.06.0410.3978/j.issn.2218676X.2015.06.04]Open DOISearch in Google Scholar
[28. Bin L, Zhang M, Lixia L, Aimin Z, Hua Y, Yanhong S, et al. Down-regulation of miRNA-30c predicts poor prognosis in Colorectal Cancer patients. Rev Romana Med Lab. 2016;24(4):369-75. DOI: 10.1515/rrlm-2016-003710.1515/rrlm-2016-0037]Open DOISearch in Google Scholar
[29. Gao LW, Wang GL. miR-190, CDK1, MCM10 and NDC80 predict the prognosis of the patients with lung cancer. Rev Romana Med Lab. 2019;27(1):15-24. DOI: 10.2478/rrlm-2019-000110.2478/rrlm-2019-0001]Search in Google Scholar
[30. Bedreag OH, Rogobete AF, Cradigati CA, Sarandan M, Nartita R, Horhat FG, et al. A novel evaluation of microvascular damage in critically ill polytrauma patients by using circulating microRNAs. Rev Romana Med Lab. 2016;24(1):21-30. DOI: 10.1515/rrlm-2016-001510.1515/rrlm-2016-0015]Open DOISearch in Google Scholar
[31. https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM509838.pdf, accessed on april 2019]Search in Google Scholar